HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal insufficiency in long-term lithium treatment.

AbstractOBJECTIVE:
To compare long-term lithium patients who developed renal insufficiency (RI) with those who did not, and to examine what characterized these groups.
METHOD:
One hundred fourteen subjects with DSM-IV bipolar, major depressive, or schizoaffective disorder who had been taking lithium for 4 to 30 years from 1968 to 2000 were studied retrospectively. Subjects with blood creatinine levels > or = 1.5 mg/dL were defined as RI patients, and creatinine levels < 1.5 mg/dL indicated no renal insufficiency (NRI). Ninety-four unmedicated subjects, matched for sex and age, served as a comparison group and had 2 measures of creatinine with a mean interval of 11.88 years.
RESULTS:
Twenty-four (21%) of the lithium-treated patients were defined as RI patients. These subjects exhibited the "creeping creatinine" phenomenon as their creatinine levels increased progressively. The NRI subjects showed no increase of creatinine levels in up to 30 years and remained comparable to the comparison group. RI was associated with episodes of lithium intoxication and diseases or medicines that could affect glomerular function, but not with sex, psychiatric diagnosis, age at onset of diagnosed disorder, duration of lithium therapy, serum lithium concentration, and cumulative lithium dose.
CONCLUSIONS:
Long-term lithium therapy did not influence glomerular function in an overwhelming majority of patients. However, about 20% of long-term lithium patients exhibited "creeping creatinine" and developed renal insufficiency.
AuthorsElie Lepkifker, Anna Sverdlik, Iulian Iancu, Reuven Ziv, Shlomo Segev, Moshe Kotler
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 65 Issue 6 Pg. 850-6 (Jun 2004) ISSN: 0160-6689 [Print] United States
PMID15291664 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Lithium
  • Creatinine
Topics
  • Adolescent
  • Adult
  • Aged
  • Creatinine (blood)
  • Depressive Disorder (blood, drug therapy)
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Lithium (adverse effects, poisoning, therapeutic use)
  • Male
  • Middle Aged
  • Psychotic Disorders (blood, drug therapy)
  • Renal Insufficiency (blood, chemically induced, diagnosis)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: